Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · IEX Real-Time Price · USD
32.47
-1.20 (-3.56%)
May 17, 2024, 4:00 PM EDT - Market closed

Collegium Pharmaceutical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2013
Revenue
566.77463.93276.87310.02296.7
Upgrade
Revenue Growth (YoY)
22.17%67.56%-10.69%4.49%5.81%
Upgrade
Cost of Revenue
240.6254.45126.25130.18193.66
Upgrade
Gross Profit
326.17209.49150.62179.84103.04
Upgrade
Selling, General & Admin
159.21172.19118.96113.83116.45
Upgrade
Research & Development
03.989.459.7710.34
Upgrade
Other Operating Expenses
004.5800
Upgrade
Operating Expenses
159.21176.17132.99123.6126.79
Upgrade
Operating Income
166.9633.3217.6356.23-23.75
Upgrade
Interest Expense / Income
83.3463.2121.0128.880.91
Upgrade
Other Expense / Income
7.89-1.05-0.01-0.23-1.94
Upgrade
Pretax Income
75.73-28.85-3.3727.58-22.72
Upgrade
Income Tax
27.58-3.85-74.890.830
Upgrade
Net Income
48.16-2571.5226.75-22.72
Upgrade
Net Income Growth
--167.33%--
Upgrade
Shares Outstanding (Basic)
3434353433
Upgrade
Shares Outstanding (Diluted)
4234413533
Upgrade
Shares Change
23.53%-17.58%16.77%5.07%1.52%
Upgrade
EPS (Basic)
1.43-0.742.050.78-0.68
Upgrade
EPS (Diluted)
1.29-0.741.860.76-0.68
Upgrade
EPS Growth
--144.74%--
Upgrade
Free Cash Flow
274.29122.61101.61-279.8321.35
Upgrade
Free Cash Flow Per Share
8.133.622.91-8.130.64
Upgrade
Gross Margin
57.55%45.15%54.40%58.01%34.73%
Upgrade
Operating Margin
29.46%7.18%6.37%18.14%-8.00%
Upgrade
Profit Margin
8.50%-5.39%25.83%8.63%-7.66%
Upgrade
Free Cash Flow Margin
48.40%26.43%36.70%-90.26%7.19%
Upgrade
Effective Tax Rate
36.41%--3.01%-
Upgrade
EBITDA
308.33173.3186.56118.07-20.77
Upgrade
EBITDA Margin
54.40%37.36%31.26%38.09%-7.00%
Upgrade
Depreciation & Amortization
149.26138.9468.9261.611.04
Upgrade
EBIT
159.0734.3717.6456.46-21.81
Upgrade
EBIT Margin
28.07%7.41%6.37%18.21%-7.35%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).